Bicycle Therapeutics plc

BCYC ·Healthcare, Drug Manufacturers - General, United Kingdom
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Assets
Cash & Equivalents $628.1M $879.5M $526.4M $339.2M $438.7M $0 $0 $0
Accounts Receivable $0 $0 $0 $2.0M $1.0M $5.5M $201.0K $5.0M
Inventory — — — — — — — —
Total Current Assets $682.9M $928.6M $561.9M $369.4M $458.6M $155.7M $104.1M $76.8M
Property, Plant & Equipment $6.0M $9.5M $14.5M $19.1M $3.1M $2.3M $2.3M $1.8M
Goodwill — — — — — — — —
Intangible Assets (Excl. Goodwill) — — — — — — — —
Total Assets $717.6M $956.9M $595.3M $410.6M $479.8M $161.2M $110.2M $81.6M
Liabilities
Accounts Payable $9.7M $15.8M $13.1M $6.5M $2.7M $1.4M $1.9M $1.9M
Total Current Liabilities $57.0M $67.2M $69.5M $53.3M $36.2M $23.1M $8.8M $8.9M
Long-Term Debt — — $30.7M $30.3M $29.9M $14.5M — —
Total Liabilities $107.6M $163.8M $224.4M $139.8M $133.5M $65.7M $17.0M $29.3M
Stockholders' Equity
Retained Earnings $-899.8M $-680.8M $-511.8M $-331.1M $-218.4M $-151.6M $-100.6M $-69.9M
Total Stockholders' Equity $610.0M $793.1M $370.9M $270.8M $346.3M $95.5M $93.2M $-69.8M